Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry-s Success

RDInvesting Provides Stocks Research on Cadence Pharmaceuticals and Opexa Therapeutics

Continue Reading

Expanding Pipelines Sends Margin Between West Texas Intermediate and Brent Crude to Narrowest in 8 Months

RDInvesting Provides Stock Research on Bill Barrett and Goodrich Petroleum

Continue Reading

Shares of Foreign Banking Stocks Fall as Cyprus Proposes Deposit Tax

RDInvesting Provides Stock Research on Banco Santander and Banco Bilbao Vizcaya Argentaria

Continue Reading

Natural Gas Producers Surge as Futures Reach a 16-Month High

Five Star Equities Provides Stock Research on Chesapeake Energy and Southwestern Energy

Continue Reading

Cyprus Proposes Tax on Deposits — Concerns Mount That Other Struggling Countries May Follow

RDInvesting Provides Stock Research on Lloyds Banking Group and National Bank of Greece

Continue Reading

Financial Sector Dragged Down by More Euro-Zone Concerns — Cyprus Proposes Tax on Deposits

RDInvesting Provides Stock Research on Morgan Stanley and Goldman Sachs

Continue Reading

FDA-s New “Breakthrough” Designation Allows New Drugs to Gain Approval after Just 1 Round of Testing

Five Star Equities Provides Stock Research on Oncolytics Biotech and XOMA

Continue Reading

U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous

RDInvesting Provides Stocks Research on Protalix BioTherapeutics and Supernus Pharmaceuticals

Continue Reading

New Programs Designed to Speed up Approval Process a Key Factor in Biotech Industry-s Growth in 2012

Five Star Equities Provides Stock Research on ImmunoCellular and Nektar

Continue Reading

Natural Gas Prices Surging in 2013 Due to Warm Weather and Falling Supplies

Five Star Equities Provides Stock Research on Quicksilver Resources and Cheniere Energy

Continue Reading